Combination of sorafenib and TACE inhibits portal vein invasion for intermediate stage HCC: a single center retrospective controlled study.

about

Combination of sorafenib and TACE inhibits portal vein invasion for intermediate stage HCC: a single center retrospective controlled study.

Item

http://www.wikidata.org/entity/Q47094775

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Combination of sorafenib and T ...... etrospective controlled study.

@en

Combination of sorafenib and T ...... etrospective controlled study.

@nl

type

Item

label

Combination of sorafenib and T ...... etrospective controlled study.

@en

Combination of sorafenib and T ...... etrospective controlled study.

@nl

prefLabel

Combination of sorafenib and T ...... etrospective controlled study.

@en

Combination of sorafenib and T ...... etrospective controlled study.

@nl

P1476

Combination of sorafenib and T ...... etrospective controlled study.

@en

P2093

Bin Xiong

http://www.w3.org/2001/XMLSchema#string

Chuansheng Zheng

http://www.w3.org/2001/XMLSchema#string

Hongsen Zhang

http://www.w3.org/2001/XMLSchema#string

Qi Yao

http://www.w3.org/2001/XMLSchema#string

P2860

Potential of immunotherapy for hepatocellular carcinoma.

Cancer statistics, 2008

Sorafenib in advanced hepatocellular carcinoma

Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

Prognosis of hepatocellular carcinoma: the BCLC staging classification

Sorafenib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study.

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials.

Novel advancements in the management of hepatocellular carcinoma in 2008.

P304

79012-79022

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.20745

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29108283

http://www.w3.org/2001/XMLSchema#string

P932

5668016

http://www.w3.org/2001/XMLSchema#string